Quanterix Co. (NASDAQ:QTRX) Shares Bought by Envestnet Asset Management Inc.

Envestnet Asset Management Inc. grew its position in Quanterix Co. (NASDAQ:QTRX) by 22.5% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 342,264 shares of the company’s stock after purchasing an additional 62,757 shares during the period. Envestnet Asset Management Inc. owned approximately 0.89% of Quanterix worth $3,638,000 as of its most recent SEC filing.

A number of other institutional investors have also modified their holdings of QTRX. Vanguard Group Inc. lifted its position in Quanterix by 0.9% during the fourth quarter. Vanguard Group Inc. now owns 2,217,225 shares of the company’s stock valued at $23,569,000 after buying an additional 19,386 shares in the last quarter. William Blair Investment Management LLC purchased a new position in shares of Quanterix in the 4th quarter valued at $11,290,000. Easterly Investment Partners LLC lifted its holdings in shares of Quanterix by 9.0% during the 4th quarter. Easterly Investment Partners LLC now owns 954,995 shares of the company’s stock valued at $10,152,000 after acquiring an additional 78,862 shares in the last quarter. Geode Capital Management LLC boosted its position in Quanterix by 0.6% during the 4th quarter. Geode Capital Management LLC now owns 863,503 shares of the company’s stock worth $9,181,000 after purchasing an additional 4,836 shares during the period. Finally, State Street Corp increased its holdings in Quanterix by 2.2% in the 3rd quarter. State Street Corp now owns 836,443 shares of the company’s stock valued at $10,840,000 after purchasing an additional 18,050 shares in the last quarter. Hedge funds and other institutional investors own 86.48% of the company’s stock.

Analysts Set New Price Targets

A number of research analysts have commented on the company. Canaccord Genuity Group reduced their price objective on Quanterix from $20.00 to $15.00 and set a “buy” rating on the stock in a research note on Tuesday, March 18th. Scotiabank reaffirmed an “outperform” rating on shares of Quanterix in a research report on Tuesday, March 25th.

Quanterix Price Performance

Shares of Quanterix stock opened at $5.60 on Friday. Quanterix Co. has a 1-year low of $4.67 and a 1-year high of $19.18. The business has a 50-day moving average of $6.58 and a 200-day moving average of $9.59. The company has a market capitalization of $217.22 million, a PE ratio of -5.28 and a beta of 1.35.

Quanterix (NASDAQ:QTRX) last announced its earnings results on Monday, March 17th. The company reported ($0.30) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.27) by ($0.03). Quanterix had a negative net margin of 30.12% and a negative return on equity of 11.74%. The business had revenue of $35.16 million during the quarter, compared to analyst estimates of $34.93 million. On average, equities analysts expect that Quanterix Co. will post -0.98 earnings per share for the current fiscal year.

Quanterix Company Profile

Quanterix Corporation, a life sciences company, engages in development and marketing of digital immunoassay platforms that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and the Asia Pacific regions. The company offers HD-X instrument, a protein detection platform; and SR-X instrument that enables researchers to apply Simoa detection in an expanded range of applications.